- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 249/10 - 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 249/10
Total number of patents in this class: 216
10-year publication summary
|
18
|
10
|
19
|
15
|
10
|
16
|
9
|
9
|
9
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 550 |
32 |
| BASF SE | 19740 |
7 |
| Bayer Pharma AG | 1096 |
7 |
| Corteva Agriscience LLC | 2494 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
6 |
| Theravance, Inc. | 93 |
6 |
| Synta Pharmaceuticals Corp. | 204 |
5 |
| Novartis AG | 11238 |
4 |
| KalVista Pharmaceuticals Limited | 111 |
4 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| Vertex Pharmaceuticals Incorporated | 1581 |
3 |
| Canopy Growth Corporation | 270 |
3 |
| FMC Corporation | 910 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 248 |
3 |
| Boehringer Ingelheim International GmbH | 4629 |
2 |
| Centre National de La Recherche Scientifique | 9632 |
2 |
| BASF AG | 1258 |
2 |
| Takeda Pharmaceutical Company Limited | 2961 |
2 |
| Ardea Biosciences, Inc. | 79 |
2 |
| BeiGene, Ltd. | 319 |
2 |
| Other owners | 111 |